Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE-/- mice

Atherosclerosis

Volumn 220, Issue 1, 2012, Pages 59-65

  Cesena, Fernando H Y ^a   Dimayuga, Paul C ^a   Yano, Juliana ^a   Zhao, Xiaoning ^a   Kirzner, Jonathan ^a   Zhou, Jianchang ^a   Chan, Lai Fan ^a   Lio, Wai Man ^a   Cercek, Bojan ^a   Shah, Prediman K ^a   Chyu, Kuang Yuh ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; IgM; Immune modulation; OxLDL antibodies

Indexed keywords

APOLIPOPROTEIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOMODULATING AGENT; POLYCLONAL ANTIBODY; POLYCLONAL IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; AORTA SINUS; ARTICLE; ATHEROGENIC DIET; CAROTID ARTERY INJURY; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE CULTURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; AUTOANTIBODIES; CAROTID ARTERY INJURIES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CHOLESTEROL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; HYPERCHOLESTEROLEMIA; IMMUNOGLOBULIN M; LIPOPROTEINS, LDL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84155172102     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.10.002     Document Type: Article

References (18)

1. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006, 6:508-519.
2. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009, 27:165-197.
3. Kuiper J., van Puijvelde G.H., van Wanrooij E.J., et al. Immunomodulation of the inflammatory response in atherosclerosis. Curr Opin Lipidol 2007, 18:521-526.
4. Nicoletti A., Kaveri S., Caligiuri G., Bariety J., Hansson G.K. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest 1998, 102:910-918.
5. Keren G., Keren P., Barshack I., Pri-Chen S., George J. The effect of intravenous immunoglobulins on intimal thickening in a mouse model of arterial injury. Atherosclerosis 2001, 159:77-83.
6. Hurez V., Kazatchkine M.D., Vassilev T., et al. Pooled normal human polyspecific IgM contains neutralizing anti-idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease. Blood 1997, 90:4004-4013.
7. Rieben R., Roos A., Muizert Y., et al. Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood 1999, 93:942-951.
8. Vassilev T., Mihaylova N., Voynova E., et al. IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice. Clin Exp Immunol 2006, 145:108-115.
9. Dimayuga P.C., Cesena F.H., Chyu K.Y., et al. Natural antibodies and complement modulate intimal thickening after arterial injury. Am J Physiol Regul Integr Comp Physiol 2009, 297:R1593-R1600.
10. Chyu K.Y., Dimayuga P., Zhu J., et al. Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ Res 1999, 85:1192-1198.
11. Faria-Neto J.R., Chyu K.Y., Li X., et al. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis 2006, 189:83-90.
12. Williams J.P., Pechet T.T., Weiser M.R., et al. Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 1999, 86:938-942.
13. Chyu K.Y., Reyes O.S., Zhao X., et al. Timing affects the efficacy of LDL immunization on atherosclerotic lesions in apo E (-/-) mice. Atherosclerosis 2004, 179:27-35.
14. Chyu K.Y., Babbidge S.M., Zhao X., et al. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 2004, 109:2448-2453.
15. Dimayuga P.C., Zhao X., Yano J., Chyu K.Y. Changes in immune responses to oxLDL epitopes during aging in hypercholesterolemic apo E (-/-) mice. Am J Physiol Regul Integr Comp Physiol 2006, 291:1644-1650.
16. Lewis M.J., Malik T.H., Ehrenstein M.R., et al. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2009, 120:417-426.
17. Zhou X., Nicoletti A., Elhage R., Hansson G.K. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000, 102:2919-2922.
18. Lobo P.I., Schlegel K.H., Spencer C.E., et al. Naturally occurring IgM anti-leukocyte autoantibodies (IgM-ALA) inhibit T cell activation and chemotaxis. J Immunol 2008, 180:1780-1791.